| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78ee87e5fae547e3e8151d576c3354e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc3c3426f2ab49c2422d356ca7c3e9f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate |
2002-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af944328d7e865cafdfbe9662a83113a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82caa04c703232b01a2e0fee3af6a391 |
| publicationDate |
2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1391207-A1 |
| titleOfInvention |
Use of a phospholipase a2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids |
| abstract |
This patent relates to the use of phospholipases, e.g.: sPLA 2 , as thenactive agent in the preparation of pharmaceutical and/or cosmeticncompositions for the treatment of pathogenias mediated by micro-organisms,nhaving a cover or membrane comprising phospholipids,nparticularly glycerophospholipids. In particular, it relates to the use of sPLA 2 nfrom the venom of Crotalus durissus terrificus as a biocide component fornthe preparation of compositions for the treatment of viral infections, innparticular the conditions of bacterial and parasitic acquirednimmunodeficiency HIV-1 and HIV-2 infections, such as parasitic conditionsnmediated by parasites from the plasmodium and leishmania species. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009018643-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1676584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009018643-A3 |
| priorityDate |
2001-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |